Lee Chien-Hsing

Lee Chien-Hsing


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TTTsai-Yi Tseng
Tsai-Yi Tseng
LCLee Chien-Hsing
Lee Chien-Hsing
HLHsiang-Lin Lee
Hsiang-Lin Lee
CSChien-Yu Su
Chien-Yu Su
Cheng-Yen KaoCheng-Yen Kao
Cheng-Yen Kao
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
Licochalcone A (LicA) is a strong anti-inflammatory, antioxidant, and anticarcinogenic substance that is useful against a variety of human malignancies. However, its precise mechanism in mediating the development of renal cell carcinoma (RCC) is not entirely understood. In this work, LicA was discovered to limit cell growth and survival, induce cell cycle arrest, promote autophagy and LC3B expression, and inhibit the migration and invasion of RCC cells. In addition, the proliferation, migration, and invasion inhibited by LicA were restored by the transfection of siRNA-LC3. The effects of LC3B on the metastatic phenotype of ACHN cells was enhanced with the overexpression of Sp1 or suppressed by inhibiting the phosphorylation of FAK and Src. Finally, LicA showed antitumor properties against RCC in an in vivo xenograft model. In conclusion, our study demonstrated the chemotherapeutic potential of LicA on proliferation, migration, invasion, and autophagy through the activation of LC3B expression, ultimately modulating FAK/Src signaling pathway-mediated Sp1 expression. These findings illustrate the novel role and molecular mechanisms of LicA against RCC cells.

1 January 2011 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
CHChien-Chou Hsiao
Chien-Chou Hsiao
LCLee Chien-Hsing
Lee Chien-Hsing
LTLon-Yen Tsao
Lon-Yen Tsao
HLHui-Chen Lo
Hui-Chen Lo
Nitric oxide synthase (NOS) inhibitors alleviate the adverse effects of nitric oxide (NO) overproduction that occurs during peritonitis, a clinical condition that is accompanied by arginine deficiency. However, the variations in the disease severity and the dosage, route, and period of NOS inhibitor administration are debatable. Therefore, we investigated the dose effects of chronically infused NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME) on the anabolism, inflammatory responses, and arginine metabolism in parenterally fed rats with cecal puncture-induced subacute peritonitis. Male Wistar rats were divided into 4 groups and were administered total parenteral nutrition solutions with 0, 5 (low dose), 25 (medium dose), or 50 (high dose) mg·kg(-1)·d(-1) of L-NAME for 7 d. Sham-operated rats administered total parenteral nutrition solution and normal healthy rats fed chow diet were also included. Our results showed that parenteral infusion significantly decreased body weight gain and plasma citrulline concentrations. In rats with subacute peritonitis, the parenteral infusion-induced increases in circulating white blood cells and NO were significantly decreased, whereas the decrease in serum albumin levels was significantly increased. Rats with subacute peritonitis that were administered chronic infusion of L-NAME had a significantly reduced nitrogen balance. In addition, rats administered the medium dose of L-NAME had significantly increased plasma arginine, ornithine, glutamate, and proline. In conclusion, chronic infusion of NOS inhibitors may not alter systemic NO homeostasis and inflammatory response but may facilitate the production of arginine-associated amino acids and nitrogen excretion in cases of subacute peritonitis.

18 August 2019 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
TTTsai‐Yi Tseng
Tsai‐Yi Tseng
HCHui‐Ling Chiou
Hui‐Ling Chiou
CLChiao‐Wen Lin
Chiao‐Wen Lin
YCYong‐Syuan Chen
Yong‐Syuan Chen
LHLi‐Sung Hsu
Li‐Sung Hsu
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh

1 January 2016 in International Surgery
Verified
Journal Article
Open access
FHFu-Huan Huang
Fu-Huan Huang
LCLee Chien-Hsing
Lee Chien-Hsing
TTTsai-Yi Tseng
Tsai-Yi Tseng
CHChing-Yi Hung
Ching-Yi Hung
The classification of choledochal cyst has changed from 3 types described by Alonso-Lej to 5 types described by Todani, but these classifications do not include dilatation of the cystic duct. The sixth type of choledochal cyst has been described by some authors for the cystic dilatation of the cystic duct. It is so rare that accurate diagnosis is difficult before operation. We present a 15-month-old girl with a type VI choledochal cyst that was misidentified preoperatively as a type I choledochal cyst. Besides the gall bladder and the cystic duct cyst, we also excised the distal part of the common bile duct and performed reconstruction with Roux-en-Y hepaticojejunostomy. From a review of the literature, we have determined that there is a more direct route to adequate diagnosis and management of the sixth type of choledochal cyst.

11 April 2008
Verified
Journal Article
Closed access
LCLee Chien-Hsing
Lee Chien-Hsing
WHWen-Tsung Hung
Wen-Tsung Hung
HLHui-Chen Lo
Hui-Chen Lo
MCMing-Chih Chou
Ming-Chih Chou
CHChing-Yi Hung
Ching-Yi Hung